Harder T
Fachgebiet Impfprävention, Robert Koch-Institut, Seestr. 10, 13353, Berlin, Deutschland.
Z Rheumatol. 2020 Nov;79(9):839-847. doi: 10.1007/s00393-020-00857-5.
By law the Standing Committee on Vaccination (STIKO) has the mandate to develop recommendations for carrying out vaccinations and other measures of specific prophylaxis of communicable diseases. Currently, the committee has 18 members who meet 3 times per year to discuss and vote on recommendations. The secretariat of STIKO is located at the Immunization Unit of the Robert Koch Institute (RKI). In 2011 the STIKO adopted a new standard operating procedure (SOP) for the development of evidence-based vaccination recommendations. Using methods of evidence-based medicine, the respective STIKO working group, comprised of STIKO members, RKI staff and external experts, develops a draft recommendation on which the commission votes. After conclusion of the external consultation procedure the vaccination recommendation is considered by the Federal Joint Committee and in the case of a positive vote, is incorporated into the guidelines for protective vaccination and therefore becomes a mandatory service of the statutory health insurance. This article provides an overview on the organization and modes of functioning of the STIKO.
根据法律规定，疫苗接种常务委员会（STIKO）的职责是制定关于实施疫苗接种及其他传染病特异性预防措施的建议。目前，该委员会有18名成员，每年召开3次会议，对建议进行讨论和表决。STIKO的秘书处设在罗伯特·科赫研究所（RKI）的免疫部门。2011年，STIKO采用了一种新的标准操作程序（SOP）来制定基于证据的疫苗接种建议。由STIKO成员、RKI工作人员和外部专家组成的相应STIKO工作组运用循证医学方法制定一份建议草案，委员会将对该草案进行表决。在外部咨询程序结束后，疫苗接种建议由联邦联合委员会审议，若表决结果为肯定，则纳入预防性疫苗接种指南，从而成为法定医疗保险的一项强制性服务。本文概述了STIKO的组织架构和运作模式。
